Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30010378HIVENSG00000140443.15protein_codingIGF1RYesNo3480C9J5X1
P08069
TVIS30076824HIVENSG00000140443.15protein_codingIGF1RYesNo3480C9J5X1
P08069
TVIS30082831HIVENSG00000140443.15protein_codingIGF1RYesNo3480C9J5X1
P08069
TVIS30039432HIVENSG00000140443.15protein_codingIGF1RYesNo3480C9J5X1
P08069
TVIS30039433HIVENSG00000140443.15protein_codingIGF1RYesNo3480C9J5X1
P08069
TVIS20001579HPVENSG00000140443.15protein_codingIGF1RYesNo3480C9J5X1
P08069
TVIS20000061HPVENSG00000140443.15protein_codingIGF1RYesNo3480C9J5X1
P08069
TVIS20000167HPVENSG00000140443.15protein_codingIGF1RYesNo3480C9J5X1
P08069
TVIS20008602HPVENSG00000140443.15protein_codingIGF1RYesNo3480C9J5X1
P08069
TVIS20006615HPVENSG00000140443.15protein_codingIGF1RYesNo3480C9J5X1
P08069
TCGA Plot Options
Drug Information
GeneIGF1R
DrugBank IDDB12267
Drug NameBrigatinib
Target IDBE0000858
UniProt IDP08069
Regulation Typeinhibitor
PubMed IDs23239810; 28597393
CitationsCeccon M, Mologni L, Bisson W, Scapozza L, Gambacorti-Passerini C: Crizotinib-resistant NPM-ALK mutants confer differential sensitivity to unrelated Alk inhibitors. Mol Cancer Res. 2013 Feb;11(2):122-32. doi: 10.1158/1541-7786.MCR-12-0569. Epub 2012 Dec 13.@@Markham A: Brigatinib: First Global Approval. Drugs. 2017 Jul;77(10):1131-1135. doi: 10.1007/s40265-017-0776-3.
GroupsApproved; Investigational
Direct ClassificationPhenylpiperidines
SMILESCOC1=CC(=CC=C1NC1=NC=C(Cl)C(NC2=CC=CC=C2P(C)(C)=O)=N1)N1CCC(CC1)N1CCN(C)CC1
Pathways
PharmGKBPA166163482
ChEMBLCHEMBL3545311